Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Northstar Gold Signs MOU with Hunan Nonferrous Ltd. to Develop Gold Resource (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Shattuck Labs Inc STTK

Healthcare Biotechnology
Shattuck Labs, Inc. is a clinical-stage biotechnology company. The Company is engaged in the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease. Its lead product candidate, SL-172154, is designed to simultaneously inhibit the CD47/SIRPa macrophage checkpoint interaction and activate the CD40... see more

Recent & Breaking News (NDAQ:STTK)

ROSEN, A TOP RANKED LAW FIRM, Encourages Shattuck Labs, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action Commenced by the Firm - STTK

PR Newswire February 1, 2022

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Shattuck Labs, Inc. with Losses of $100,000 to Contact the Firm

Business Wire January 31, 2022

(STTK) DEADLINE: Did You Suffer a Substantial Loss? Contact Johnson Fistel About Leading Shattuck Labs Class Action Lawsuit

Newsfile January 31, 2022

EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against Shattuck Labs, Inc. - STTK

Business Wire January 31, 2022

ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Shattuck Labs, Inc. Investors with Losses to Inquire About Class Action Investigation - STTK

PR Newswire January 27, 2022

Shattuck Labs Announces Participation in Upcoming January Investor Conferences

GlobeNewswire January 5, 2022

Rosen, Globally Recognized Investor Counsel, Encourages Shattuck Labs, Inc. Investors with Losses to Inquire About Class Action Investigation - STTK

Newsfile December 30, 2021

STTK Equity Alert: Rosen, Leading Investor Counsel, Encourages Shattuck Labs, Inc. Investors with Losses to Inquire About Class Action Investigation - STTK

Newsfile December 18, 2021

STTK INVESTOR NOTICE: ROSEN, A TOP RANKED LAW FIRM, Encourages Shattuck Labs, Inc. Investors with Losses to Inquire About Class Action Investigation - STTK

Newsfile December 7, 2021

ONGOING INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Shattuck Labs, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm

Newsfile December 3, 2021

Shattuck Labs to Present at TIGIT Therapies Digital Summit 2021

GlobeNewswire December 2, 2021

STTK BREAKING NEWS: ROSEN, A LEADING NATIONAL FIRM, Encourages Shattuck Labs, Inc. Investors with Losses to Inquire About Class Action Investigation - STTK

PR Newswire December 1, 2021

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Shattuck Labs, Inc. - STTK

Newsfile November 28, 2021

INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Shattuck Labs, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm

Business Wire November 26, 2021

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Shattuck Labs, Inc. - STTK

PR Newswire November 25, 2021

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Shattuck Labs, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm

Business Wire November 23, 2021

EQUITY ALERT: Rosen Law Firm Encourages Shattuck Labs, Inc. Investors with Losses to Inquire About Class Action Investigation - STTK

Business Wire November 22, 2021

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Shattuck Labs, Inc. - STTK

PR Newswire November 15, 2021

Shattuck Labs Reports Third Quarter 2021 Financial Results and Recent Business Highlights

GlobeNewswire November 9, 2021

Shattuck Labs Announces Preliminary Clinical Data from Ongoing Phase 1 Clinical Trials of ARC Fusion Proteins SL-172154 and SL-279252

GlobeNewswire November 9, 2021